JPWO2020144239A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020144239A5
JPWO2020144239A5 JP2021539653A JP2021539653A JPWO2020144239A5 JP WO2020144239 A5 JPWO2020144239 A5 JP WO2020144239A5 JP 2021539653 A JP2021539653 A JP 2021539653A JP 2021539653 A JP2021539653 A JP 2021539653A JP WO2020144239 A5 JPWO2020144239 A5 JP WO2020144239A5
Authority
JP
Japan
Prior art keywords
kda
composition
optionally
formula
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021539653A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022517939A (ja
JP7680355B2 (ja
Publication date
Priority claimed from GBGB1900258.3A external-priority patent/GB201900258D0/en
Application filed filed Critical
Publication of JP2022517939A publication Critical patent/JP2022517939A/ja
Publication of JPWO2020144239A5 publication Critical patent/JPWO2020144239A5/ja
Priority to JP2024229910A priority Critical patent/JP2025066716A/ja
Application granted granted Critical
Publication of JP7680355B2 publication Critical patent/JP7680355B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021539653A 2019-01-08 2020-01-08 医薬組成物 Active JP7680355B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024229910A JP2025066716A (ja) 2019-01-08 2024-12-26 医薬組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1900258.3A GB201900258D0 (en) 2019-01-08 2019-01-08 Pharmaceutical composition
GB1900258.3 2019-01-08
PCT/EP2020/050333 WO2020144239A1 (en) 2019-01-08 2020-01-08 Pharmaceutical composition

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024229910A Division JP2025066716A (ja) 2019-01-08 2024-12-26 医薬組成物

Publications (3)

Publication Number Publication Date
JP2022517939A JP2022517939A (ja) 2022-03-11
JPWO2020144239A5 true JPWO2020144239A5 (enrdf_load_stackoverflow) 2023-01-23
JP7680355B2 JP7680355B2 (ja) 2025-05-20

Family

ID=65528088

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021539653A Active JP7680355B2 (ja) 2019-01-08 2020-01-08 医薬組成物
JP2024229910A Pending JP2025066716A (ja) 2019-01-08 2024-12-26 医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024229910A Pending JP2025066716A (ja) 2019-01-08 2024-12-26 医薬組成物

Country Status (25)

Country Link
US (2) US20220118003A1 (enrdf_load_stackoverflow)
EP (2) EP4289429A3 (enrdf_load_stackoverflow)
JP (2) JP7680355B2 (enrdf_load_stackoverflow)
KR (1) KR20210113251A (enrdf_load_stackoverflow)
CN (1) CN113543775B (enrdf_load_stackoverflow)
AU (1) AU2020205438B9 (enrdf_load_stackoverflow)
BR (1) BR112021013456A2 (enrdf_load_stackoverflow)
CA (1) CA3125372A1 (enrdf_load_stackoverflow)
DK (1) DK3908321T3 (enrdf_load_stackoverflow)
EA (1) EA202191603A1 (enrdf_load_stackoverflow)
ES (1) ES2968432T3 (enrdf_load_stackoverflow)
FI (1) FI3908321T3 (enrdf_load_stackoverflow)
GB (1) GB201900258D0 (enrdf_load_stackoverflow)
HR (1) HRP20231667T1 (enrdf_load_stackoverflow)
HU (1) HUE064916T2 (enrdf_load_stackoverflow)
LT (1) LT3908321T (enrdf_load_stackoverflow)
MX (1) MX2021008248A (enrdf_load_stackoverflow)
PH (1) PH12021551642A1 (enrdf_load_stackoverflow)
PL (1) PL3908321T3 (enrdf_load_stackoverflow)
PT (1) PT3908321T (enrdf_load_stackoverflow)
RS (1) RS65067B1 (enrdf_load_stackoverflow)
SI (1) SI3908321T1 (enrdf_load_stackoverflow)
SM (1) SMT202400011T1 (enrdf_load_stackoverflow)
WO (1) WO2020144239A1 (enrdf_load_stackoverflow)
ZA (1) ZA202104704B (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112024002231A2 (pt) 2021-08-05 2024-04-30 Medincell S A Composição farmacêutica
WO2025104289A1 (en) 2023-11-17 2025-05-22 Medincell S.A. Antineoplastic combinations

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2016A (en) 1841-03-26 Mode of constructing fireplaces and chimney-staoks ii
FR2741628B1 (fr) 1995-11-29 1998-02-06 Centre Nat Rech Scient Nouveaux hydrogels a base de copolymeres trisequences et leur application notamment a la liberation progressive de principes actifs
US6461631B1 (en) 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
KR100416242B1 (ko) * 1999-12-22 2004-01-31 주식회사 삼양사 약물전달체용 생분해성 블록 공중합체의 액체 조성물 및이의 제조방법
US7649023B2 (en) * 2002-06-11 2010-01-19 Novartis Ag Biodegradable block copolymeric compositions for drug delivery
JP5539725B2 (ja) 2006-11-27 2014-07-02 アクタマックス サージカル マテリアルズ リミテッド ライアビリティ カンパニー 分岐末端反応物及びそれから製造されるポリマーヒドロゲル組織接着剤
US9248165B2 (en) * 2008-11-05 2016-02-02 Hancock-Jaffe Laboratories, Inc. Composite containing collagen and elastin as a dermal expander and tissue filler
MA34832B1 (fr) 2010-12-29 2014-01-02 Medincell Compositions biodegradables d'administration de medicaments
CN102432852B (zh) * 2011-08-25 2013-10-16 复旦大学 一种聚乳酸基立构复合交联共聚物及其制备方法
WO2014001904A1 (en) * 2012-06-27 2014-01-03 Medincell Biodegradable drug delivery for hydrophobic compositions
EP2983716A4 (en) 2013-04-11 2017-01-25 Commonwealth Scientific and Industrial Research Organisation Composition for controlled delivery of bioactive agents
EP3936115A1 (en) * 2014-04-21 2022-01-12 Heron Therapeutics, Inc. Long-acting polymeric delivery systems
EP4374861A3 (en) 2015-11-16 2024-08-07 MedinCell S.A. A method for morselizing and/or targeting pharmaceutically active principles to synovial tissue
HRP20250339T1 (hr) 2017-07-17 2025-05-09 Medincell S.A. Farmaceutski pripravak
CN108586775B (zh) * 2018-05-04 2019-11-12 四川大学 可用于眼内长期填充的原位交联超支化聚醚类水凝胶及其制备方法

Similar Documents

Publication Publication Date Title
US8674032B2 (en) Biodegradable multi-block co-polymers
JP4753992B2 (ja) 新規な温度及びｐＨ感受性のブロック共重合体及びこれを用いた高分子ヒドロゲル
KR100558025B1 (ko) 가역성 열 젤화 특성을 보유한 생분해성 저분자량 삼블록폴리에스테르 폴리에틸렌 글리콜 공중합체
US9155722B2 (en) Reconstitutable reverse thermal gelling polymers
US8674033B2 (en) Biodegradable phase separated segmented multi block co-polymers
DK1778191T3 (en) Biodegradable DIBLOKCOPLYMERE having reverse thermal gelling properties, and methods of use thereof
US8753621B2 (en) BAB triblock polymers having improved release characteristics
AU2006271727A1 (en) Resorbable polyether esters for producing medical implants
DK2478066T3 (en) BAB TRIBLOCK POLYMERS WITH IMPROVED DELIVERY CHARACTERISTICS
JP4524923B2 (ja) ポリマー、生体内分解性材料および用途
CA2774525C (en) Reconstitutable reverse thermal gelling polymers
JPWO2020144239A5 (enrdf_load_stackoverflow)
HRP20231667T1 (hr) Farmaceutski pripravak
CN101450989A (zh) 一种原位合成聚羟基脂肪酸酯嵌段共聚物的方法
JP6176998B2 (ja) 温度応答性生分解性高分子組成物及びその製造方法
US20250034331A1 (en) Polyester urethane bioresorbable elastomers with microstructures for tunable drug release and tunable degradation
EA045374B1 (ru) Фармацевтическая композиция
JP2023532582A (ja) 医薬組成物
HK1173168A (en) Reconstitutable reverse thermal gelling polymers
HK1173174B (en) Bab triblock polymers having improved release characteristics
HK1173174A (en) Bab triblock polymers having improved release characteristics